Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-01-06 @ 3:01 PM
Study NCT ID:
NCT04160494
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-11
First Post:
2019-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
D2C7-IT With Atezolizumab for Recurrent Gliomas
Sponsor:
Darell Bigner
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-08
First Submit QC Date:
None
Study First Post Date:
2019-11-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-08
Last Update Post Date:
2025-05-11
Last Update Post Date Type:
ACTUAL